Key facts
- It has raised $21.4M; the latest was Secondary Transaction - Private in Jun 2024.
- Notable investors include Bpifrance, Supernova Invest, Turenne Groupe, Korys Investments, Catp Expansion — 8 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 8 names
- ·Watchlist + deal alerts for Cairdac
- ·The full record, as it builds
Funding rounds
No funding rounds for Cairdac are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Cairdac
Developer of a pacing device designed to maintain cardiac rhythm. The company's implanted leadless pacemakers incorporate a self-sustaining power patented technology harvesting the heart's kinetic energy and bringing disruptive technologies to conventional leadless pacemakers, enabling healthcare professionals to get cost-effective alternatives to revolutionize patients' quality of life.
- Sector
- Healthcare
- HQ
- Paris, France
- Founded
- 2016
- Employees
- 37
- Website
- cairdac.com/
- Ownership
- Privately Held (backing)
Cairdac doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Cairdac shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Cairdac in its N-PORT filings yet. We sweep new filings monthly.